Barlaam; Bernard
Patent Applications and Registrations
Patent applications and USPTO patent grants for Barlaam; Bernard.The latest application filed is for "chemical compounds".
- Barlaam; Bernard - Cambridge GB
- Barlaam; Bernard - Macclesfield GB
- Barlaam; Bernard - Sodertalje SE
- Barlaam; Bernard - Reims FR
| Patent | Date |
|---|---|
| Pyridine and pyrimidine derivatives Grant 11,352,369 - Barlaam , et al. June 7, 2 | 2022-06-07 |
| Chemical Compounds App 20210171541 - Barlaam; Bernard ; et al. | 2021-06-10 |
| Chemical compounds Grant 10,717,746 - Barlaam , et al. | 2020-07-21 |
| Chemical Compounds App 20180093998 - Barlaam; Bernard ; et al. | 2018-04-05 |
| Chemical compounds Grant 9,845,331 - Barlaam , et al. December 19, 2 | 2017-12-19 |
| Chemical Compounds App 20160376287 - Barlaam; Bernard ; et al. | 2016-12-29 |
| 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)pip- eridin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same Grant 8,318,752 - Barlaam November 27, 2 | 2012-11-27 |
| Novel Compounds App 20120095011 - Barlaam; Bernard ; et al. | 2012-04-19 |
| Novel Compounds App 20090131463 - Barlaam; Bernard ; et al. | 2009-05-21 |
| Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (IGF-I) Grant 7,521,453 - Barlaam , et al. April 21, 2 | 2009-04-21 |
| ER-beta-selective ligands App 20070208066 - Barlaam; Bernard ; et al. | 2007-09-06 |
| Selective estrogen receptor-.beta. ligands Grant 7,256,201 - Barlaam , et al. August 14, 2 | 2007-08-14 |
| Estrogen receptor-.beta. ligands Grant 7,226,945 - Barlaam , et al. June 5, 2 | 2007-06-05 |
| Therapeutic benimidazole compounds App 20070004713 - Barlaam; Bernard ; et al. | 2007-01-04 |
| Therapeutic benzothiazole compounds App 20060111408 - Barlaam; Bernard ; et al. | 2006-05-25 |
| Therapeutic benzoxazole compounds Grant 7,045,539 - Barlaam , et al. May 16, 2 | 2006-05-16 |
| Selective estrogen receptor-beta ligands App 20050101584 - Barlaam, Bernard ; et al. | 2005-05-12 |
| Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-i) App 20050054638 - Barlaam, Bernard ; et al. | 2005-03-10 |
| Estrogen Receptor-beta ligands App 20050043350 - Barlaam, Bernard ; et al. | 2005-02-24 |
| Therapeutic compounds App 20040102435 - Barlaam, Bernard ; et al. | 2004-05-27 |
| Estrogen Receptor-beta ligands App 20040039015 - Barlaam, Bernard ; et al. | 2004-02-26 |
| Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents App 20030139419 - Barlaam, Bernard ; et al. | 2003-07-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 